Search - tctmd.com

Displaying 81 - 100 of 482

Sort: Relevancy | Date

Presentation TCT 2023

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

Presenter: Won-Keun Kim

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Presenter: Kendra Grubb

October 24, 2023

Presentation TCT 2023

TCT 895: Percutaneous Closure of Aortic Root to Right Ventricular Outflow Tract Fistula Following Surgical Aortic Valve Replacement

Presenter: Amjed Zidan

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

News Daily News

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Yael L. Maxwell

September 06, 2023

News Daily News

Abbott to Stop Making Trifecta Surgical Aortic Valves

Michael O'Riordan

July 31, 2023

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News EuroPCR 2023

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

Shelley Wood

May 17, 2023

News Conference News AATS 2023

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

Michael O'Riordan

May 11, 2023

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

Todd Neale

March 05, 2023

Advertisement

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

TCT 895: Percutaneous Closure of Aortic Root to Right Ventricular Outflow Tract Fistula Following Surgical Aortic Valve Replacement

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Abbott to Stop Making Trifecta Surgical Aortic Valves

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content